Literature DB >> 22262735

Reverse cardiac remodelling and renal functional improvement following bilateral renal artery stenting for flash pulmonary oedema.

Constantina Chrysochou1, Matthias Schmitt, Kirk Siddals, Julie Hudson, Alan Fitchet, Philip A Kalra.   

Abstract

Acute flash pulmonary oedema (AFPO) is a life-threatening syndrome almost unique to patients with atheromatous renovascular disease (ARVD). Although recurrent AFPO is a widely accepted indication to consider renal revascularization, this is based on a number of case reports/series describing a successful outcome post-procedure. There is limited literature on the pathophysiological mechanisms and treatment effects of revascularization to support this clinical decision making. We report the case of a 65-year-old lady who presented with three episodes of AFPO. Investigations revealed severe bilateral renal artery stenosis. Post-revascularization, she experienced substantial improvement in energy levels and New York Heart Association class, with improvement in her blood pressure and renal function. Post-procedure, there were dramatic improvements in her cardiac morphology and function that were sustained at 1 year (ejection fraction improved from 39 to 65%, left ventricular mass decreased from 161 to 116 g) as well as renal function (isotopic glomerular filtration rate increased from 22.4 to 34.2 mL/min). This report provides new insights into the pathophysiological relationships between renal and cardiac changes in AFPO; the extent of the cardiac morphological changes was striking and unexpected.

Entities:  

Mesh:

Year:  2012        PMID: 22262735     DOI: 10.1093/ndt/gfr745

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

Review 1.  Renovascular hypertension: is there still a role for stent revascularization?

Authors:  Stephen C Textor
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-09       Impact factor: 2.894

Review 2.  Renal artery stenosis: medical versus interventional therapy.

Authors:  Stephen C Textor; Lilach O Lerman
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

3.  Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel study.

Authors:  Osami Kawarada; Teruyoshi Kume; Kan Zen; Shigeru Nakamura; Koji Hozawa; Tadafumi Akimitsu; Hiroshi Asano; Hiroshi Ando; Yoshito Yamamoto; Takehiro Yamashita; Norihiko Shinozaki; Keita Odashiro; Tadaya Sato; Kenichiro Yuba; Yuji Sakanoue; Takashi Uzu; Kozo Okada; Peter J Fitzgerald; Yasuhiro Honda; Satoshi Yasuda
Journal:  ESC Heart Fail       Date:  2019-01-07

4.  Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study.

Authors:  Darren Green; Diana Vassallo; Kelly Handley; Natalie Ives; Keith Wheatley; Constantina Chrysochou; Janet Hegarty; Julian Wright; Jon Moss; Rajan K Patel; Chris Deighan; John Webster; Peter Rowe; Sue Carr; Jenny Cross; Jamie O'Driscoll; Raj Sharma; Patrick Mark; Philip A Kalra
Journal:  BMC Nephrol       Date:  2019-06-14       Impact factor: 2.388

5.  Renal artery intervention for a patient with flash pulmonary edema accompanied by elevation of troponin levels due to bilateral renal artery stenosis and multivessel coronary disease: a case report.

Authors:  Ruxian Sun; Biao Li; Xiwei Chen; Yaogui Chen; Li Li
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.